*Childhood-Onset Ataxia DOI: http://dx.doi.org/10.5772/intechopen.112968*

[19] Wang CX. Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric patient. Pediatric Drugs. 2021;**23**:213-221

[20] Pavone P, Pettoello-Mantovano M, Le Pira A, et al. Acute disseminated encephalomyelitis: A long-term prospective study and meta-analysis. Neuropediatrics. 2010;**41**:246-255

[21] Shilo S, Michaeli O, Shahar E, et al. Long-term motor, cognitive and behavioural outcome of acute disseminated encephalomyelitis. European Journal of Paediatric Neurology. 2016;**20**:361-367

[22] Beatty C, Bowler RA, Farooq O, et al. Long-term neurocognitive, psychosocial, and magnetic resonance imaging outcomes in Pediatric-onset acute disseminated encephalomyelitis. Pediatric Neurology. 2016;**57**:64-73

[23] Brunklaus A, Pohl K, Zuberi SM, et al. Outcome and prognostic features in Opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics. 2011;**128**:e388-e394

[24] Galstyan A, Wilbur C, Selby K, et al. Opsoclonus-myoclonus syndrome: A new era of improved prognosis? Pediatric Neurology. 2017;**72**:65-69

[25] Blaes F, Dharmalingam B. Childhood opsoclonus-myoclonus syndrome: Diagnosis and treatment. Expert Review of Neurotherapeutics. 2016;**16**:641-648

[26] Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Histopathologic features-a report from the children's cancer group. Medical and Pediatric Oncology. 2001;**36**:623-629

[27] Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: Primary brain and other central nervous system Tumors diagnosed in the United States in 2013- 2017. Neuro-oncology. 2020;**22**:iv1-iv96

[28] Rickert C, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Child's Nervous System. 2001;**17**:503-511

[29] Aneja S, Sharma S. Diagnosis and Management of Acute Encephalitis in children. Indian Journal of Pediatrics. 2019;**86**:70-75

[30] Yeshokumar AK, Sun LR, Klein JL, et al. Gait disturbance as the presenting symptom in young children with anti-NMDA receptor encephalitis. Pediatrics. 2016;**138**:e20160901

[31] Baizabal-Carvallo JF, Stocco A, Muscal E, et al. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis: Anti-Nmdar encephalitis movement disorders. Movement Disorders. 2013;**28**:543-547

[32] Goldberg EM, Titulaer M, de Blank PM, et al. Anti–N-methyl-Daspartate receptor-mediated encephalitis in infants and toddlers: Case report and review of the literature. Pediatric Neurology. 2014;**50**:181-184

[33] Caffarelli M, Kimia AA, Torres AR. Acute ataxia in children: A review of the differential diagnosis and evaluation in the emergency department. Pediatric Neurology. 2016;**65**:14-30

[34] Overby P, Kapklein M, Jacobson RI. Acute ataxia in children. Pediatrics in Review. 2019;**40**:332-343

[35] Salman MS, Klassen SF, Johnston JL. Recurrent ataxia in children and

adolescents. Canadian Journal of Neurological Sciences. 2017;**44**:375-383

[36] Fernández-Alvarez E, Perez-Dueñas B. Paroxysmal movement disorders and episodic ataxias. Handbook of Clinical Neurology. 2013;**112**:847-852. DOI: 10.1016/ B978-0-444-52910-7.00004-0

[37] Kipfer S, Strupp M. The clinical Spectrum of autosomal-dominant episodic ataxias. Movement Disorders Clinical Practice. 2014;**1**:285-290

[38] Garone G, Capuano A, Travaglini L, et al. Clinical and genetic overview of paroxysmal movement disorders and episodic ataxias. International Journal of Molecular Sciences. 2020;**21**:3603

[39] Jen JC, Wan J. Episodic ataxias. Handbook of Clinical Neurology. 2018;**148**:521-529. DOI: 10.1016/ B978-0-444-64076-5.00033-8

[40] Koch H, Weber YG. The glucose transporter type 1 (Glut1) syndromes. Epilepsy & Behavior. 2019;**91**:90-93

[41] Gras D, Roze E, Caillet S, et al. GLUT1 deficiency syndrome: An update. Revue Neurologique (Paris). 2014;**170**:91-99

[42] Duat Rodriguez A, Prochazkova M, Santos Santos S, et al. Early diagnosis of CAPOS syndrome before acute-onset ataxia—Review of the literature and a new family. Pediatric Neurology. 2017;**71**:60-64

[43] Salles PA, Mata IF, Brünger T, et al. ATP1A3-related disorders: An everexpanding clinical Spectrum. Frontiers in Neurology. 2021;**12**:637890

[44] Carecchio M, Zorzi G, Ragona F, et al. ATP1A3-related disorders: An

update. European Journal of Paediatric Neurology. 2018;**22**:257-263

[45] Debray F-G, Lambert M, Gagne R, et al. Pyruvate dehydrogenase deficiency presenting as intermittent isolated acute ataxia. Neuropediatrics. 2008;**39**:20-23

[46] Pavuluri H, Alfiya F, Menon RN, et al. Pyruvate dehydrogenase complex deficiency due to PDHA1 mutation—A rare treatable cause for episodic ataxia in children. Indian Journal of Pediatrics. 2022;**89**:519-519

[47] Raslan IR, Barsottini OG, Pedroso JL. A proposed clinical classification and a diagnostic approach for congenital ataxias. Neurology: Clinical Practice. 2021;**11**:e328-e336

[48] Bertini E et al. Nonprogressive congenital ataxias. Handbook of Clinical Neurology. 2018;**155**:91-103. DOI: 10.1016/B978-0-444-64189-2.00006-8

[49] Correa GG, Amaral LF, Vedolin LM. Neuroimaging of Dandy-Walker malformation: New concepts. Topics in Magnetic Resonance Imaging. 2011;**22**:303-312

[50] Romani M, Micalizzi A, Valente EM. Joubert syndrome: Congenital cerebellar ataxia with the molar tooth. Lancet Neurology. 2013;**12**:894-905

[51] van Dijk T, Baas F, Barth PG, et al. What's new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet Journal of Rare Diseases. 2018;**13**:92

[52] Soong B-W, Morrison PJ. Spinocerebellar ataxias. Handbook of Clinical Neurology. 2018; **155**:143-174. DOI: 10.1016/ B978-0-444-64189-2.00010-X
